Sponsor or institution
Clinical trials and research at Royal Marsden NHS Foundation Trust
As of November 12, 2026, Find a Trial lists 30 clinical trials run by Royal Marsden NHS Foundation Trust that are recruiting, at sites in 3 countries (most in United Kingdom (30), Canada (1), France (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 30Clinical trials
- 3Countries
Newest trials
All recruiting trials (30)
-
Genetic Risk Profiling in Prostate Cancer: Patient and Provider Perspectives
This study asks patients and their doctors how genetic risk profiling for prostate cancer might fit into routine care and decision-making.
-
Short-course CT online-adaptive radiotherapy for post-operative endometrial cancer
This trial tests whether delivering post-operative radiotherapy in 5 sessions using CT online-adaptive radiotherapy is safe and feasible for endometrial cancer patients.
-
ctDNA-guided precision care for lung, GIST, colorectal, biliary, and ovarian cancers
This trial tests a blood test that looks for tumor DNA in patients with several cancers to help guide personalized treatment decisions.
-
Personalised neoadjuvant therapy planning for adults with high‑risk soft tissue sarcoma
This project tests whether analyzing tumor tissue and clinical data can help guide neoadjuvant chemotherapy decisions for adults with high‑risk soft tissue sarcomas.
-
Digital exercise program with live virtual group sessions for men on hormone therapy during radiotherapy
This program will test whether a digital exercise program with live virtual group sessions helps men with prostate cancer who are starting or receiving hormone therapy with radiotherapy stick to exercise recommendations and improve health and fatigue.
-
Immediate breast reconstruction using 3D imaging and simulation to measure effects of radiotherapy
This project will test whether 3D surface photos and simulated images help women having a mastectomy with immediate reconstruction feel more confident about their likely appearance, help surgeons plan to reduce later correction surgery, and measure how radiotherapy changes breast shape.
-
Serial multisite image-guided biopsies to track breast cancer evolution
The team will try taking repeated image-guided biopsies and blood samples from adults with metastatic or advanced breast cancer to see how their tumors change during treatment.
-
Collecting blood and viable tumor samples from people with oncogene-driven or neoadjuvantly treated non-small cell lung cancer.
This project will try to see if paired blood and viable tumor samples can be reliably collected from adults with oncogene-driven advanced NSCLC starting targeted therapy and from adults with stage II–III NSCLC receiving neoadjuvant immunotherapy.
-
High-dose radiotherapy for renal cell carcinoma treatment
This study is testing whether a higher dose of radiation therapy can be a better option for people with kidney cancer compared to the standard treatment.
-
Increasing radiotherapy doses for rectal cancer treatment
This study tests if giving a higher dose of radiation can help people with advanced rectal cancer avoid surgery by seeing if it leads to better treatment results.
-
Using video capsules to examine patients with Lynch Syndrome
This study is testing whether video capsules can be a good alternative to regular colonoscopies for people with Lynch Syndrome to help improve cancer screening.
-
Understanding breast cancer response during pre-surgery treatment
This study is trying to see how breast cancer responds to treatment before surgery by looking at tissue and blood samples from patients to find out what factors might affect their recovery and risk of cancer coming back.
-
Two-session MR‑Linac radiotherapy with targeted dose reduction for intermediate‑risk prostate cancer
This trial tests whether two MR‑guided radiotherapy sessions with a lower dose to non‑tumor prostate tissue can reduce side effects for men with intermediate‑risk prostate cancer while keeping tumor control.
-
Using PSMA-PET to guide melanoma surgery planning
We will see if a PSMA PET/CT scan can find melanoma spread more clearly than the standard FDG PET/CT in adults with palpable lymph nodes or limited metastatic melanoma who are scheduled for surgery.
-
Mobile health outreach for men's cancer screening
This study is testing a mobile health service that brings cancer screening directly to men at their workplaces, especially those in high-risk groups, to help them get checked for prostate cancer and other urological issues.
-
Transoral robotic surgery for early oropharyngeal cancer
This study is testing how well transoral robotic surgery works for people with early-stage throat cancer and whether it helps them avoid cancer coming back, while also looking at any complications and other factors that might affect their recovery.
-
Developing tests to identify cancer in patients with vague symptoms
This study is testing new blood and non-blood tests to see if they can quickly identify cancer in people with unclear but worrying symptoms.
-
Investigating the role of ctDNA in advanced thyroid cancer
This study is trying to see if analyzing blood samples for tumor DNA can help doctors better understand and treat advanced thyroid cancer.
-
CLIMB: using scans and tissue biomarkers to learn more about primary CNS lymphoma
This project will try to use brain scans and tumour tissue from adults with newly diagnosed primary CNS lymphoma to find markers that predict treatment response and time without disease progression.
-
Investigating outcomes after salvage surgery for recurrent head and neck cancer
This study tests how well salvage surgery works for people with recurrent head and neck cancer and looks at how genetics and past treatments might affect their recovery and quality of life.
-
Collecting cancer samples to create living models for research
This study is collecting cancer samples from patients to create lab-grown models that help researchers understand why some cancers respond to treatment better than others.
-
Reducing radiation doses in prostate cancer treatment using advanced technology
This study is testing whether using advanced technology can safely lower radiation doses in men with intermediate risk prostate cancer while still keeping their PSA levels under control.
-
Blood biomarker study for early lung cancer diagnosis
This study is testing if certain blood markers can help tell if lung nodules are harmless or cancerous in patients who have had lung cancer before.
-
Understanding immune-related toxicities in cancer patients receiving therapy
This study is trying to learn more about the side effects that cancer patients may experience while receiving a new type of treatment called immune checkpoint inhibitors.
-
Evaluation of new magnetic resonance imaging techniques
This study is testing new MRI techniques on patients and healthy volunteers to see if they provide better images and measurements than the standard methods.
-
Reducing chemotherapy for early-stage breast cancer
This study is testing if checking blood for tumor DNA can help doctors decide if some early-stage breast cancer patients can safely have less chemotherapy after surgery.
-
Detecting and treating early breast cancer relapse using ctDNA analysis
This study is testing if checking for cancer DNA in the blood can help catch early breast cancer relapses in women with a specific type of breast cancer and see if treating those at risk with a new combination of medications can improve their chances of staying cancer-free.
-
Exploring cancer evolution in patients with head and neck tumors after radiation therapy
This study is trying to understand how head and neck tumors change after radiation therapy to help doctors find better treatments for patients with these cancers.
-
Tracking mutations in blood to predict relapse in early colorectal cancer
This study is testing if tracking certain DNA changes in the blood can help predict if people with early colorectal cancer will have a relapse after surgery.
-
Analyzing leftover tumor tissue for better cancer diagnosis
This study is testing if blending leftover tumor tissue from cancer surgeries can help create better samples for diagnosing cancer more accurately.
Quick answers
How many clinical trials run by Royal Marsden NHS Foundation Trust are recruiting right now?
30, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United Kingdom (30 trials), Canada (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.